Monthly Drug Regimen Review
UPDATED 2024
Provides a document for the licensed pharmacist to effectively communicate and follow-up on his/her findings from the monthly drug regimen review. Updated to reflect regulatory changes for the pharmacist to review each resident’s medical record as well as report any irregularities to the attending physician, Medical Director and Director of Nursing.
NOTE: CFS12-7Eis a companion document from the pharmacist to the attending physician, Medical Director and Director of Nursing. CFS12-7/5P provides for response documentation by the attending physician as required in §483.45(c)(4) – F756.
- Size: 8 ½” x 11
- White paper, black ink
- 5-hole punched top and side
- 100 per pad